Not only to remain alive but all 12 still have full ability to swallow, thats huge as we know how debilitating this disease can be it has to be halting progression fairly significantly
- Forums
- ASX - By Stock
- PAA
- Ann: Extension Study Begins, Analysis Suggests Survival Benefit
Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-9
-
-
- There are more pages in this discussion • 189 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.90M |
Open | High | Low | Value | Volume |
22.0¢ | 22.0¢ | 22.0¢ | $78.95K | 358.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 118422 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 71000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 118422 | 0.215 |
5 | 281446 | 0.210 |
5 | 371081 | 0.205 |
12 | 437180 | 0.200 |
11 | 322463 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 71000 | 3 |
0.230 | 173257 | 6 |
0.235 | 55395 | 2 |
0.240 | 159752 | 3 |
0.245 | 196127 | 3 |
Last trade - 10.35am 16/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online